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Abstract 
In patients with guanidinoacetate methyltransferase (GAMT) deficiency several parameters 
may point towards the diagnosis of GAMT deficiency. These include the low levels of 
creatine and creatinine in urine, the high concentration of guanidinoacetic acid (GAA) in 
urine and the low levels of creatine and creatinine in the cerebrospinal fluid (CSF). In this 
study, body fluids from 10 GAMT deficient patients were analysed using (1)H NMR 
spectroscopy. The urine 1D (1)H NMR spectra of all the patients showed a doublet resonance 
at 3.98 ppm (pH 2.50) derived from GAA present in high concentration. For this compound, 
a good recovery and good correlation was found between an LC-MS/MS method and (1)H 
NMR spectroscopy. In CSF NMR spectra of these patients, the singlet resonances of creatine 
and creatinine (3.05 and 3.13 ppm, respectively) were absent (normally always present in 
(1)H NMR spectra of CSF). Due to overlap by other resonances, the doublet of GAA could 
not be observed. Our data demonstrate that (1)H NMR spectroscopy of urine and CSF can be 
used to diagnose patients with GAMT deficiency. 
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